> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# More Repackagers Involved in Valsartan Recall
- URL: https://www.fdaweb.com/more-repackagers-involved-in-valsartan-recall/
- Published: 2018-07-30T12:00:00.000Z
- Updated: 2026-09-15T00:22:47.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5141988

FDA says it has found that several additional drug repackagers are recalling valsartan-containing products. In its latest product recall [update](https://www.fda.gov/Drugs/DrugSafety/ucm613916.htm?utm%5Fcampaign=FDA%20MedWatch%20Recall%20Notice%20-%20FDA%20updates%20on%20valsartan%20recalls&utm%5Fmedium=email&utm%5Fsource=Eloqua), the agency says it has recall information from three additional repackagers of valsartan-containing products made by Teva and Prinson, labeled as A-S Medication Solutions, AvKARE, and RemedyRepack. They have been added to the recalled products list.

The update also says these additional repackagers are recalling or are expected to recall valsartan-containing products — Bryan Ranch Prepack, H.J. Harkins Company, Lake Erie Medical (Quality Care Products LLC), NuCare Pharmaceuticals, Northwind Pharmaceuticals, and Proficient Rx. Some of the companies may be producing valsartan-containing products that are not covered by the recall, the notice says.

FDA 7/13 announced a recall of certain batches of valsartan tablets because of an impurity, a chemical known as N-nitrosodimethylamine that has been found to increase the occurrence of cancer in animal studies.